Related content

Distinctive multidrug sensitivity and outcome of acute erythroblastic and megakaryoblastic leukemia in children with down syndrome

By Yamada Sayuri   Hongo Teruaki   Okada Shuichi   Watanabe Chieko   Fujii Yuji   Hori Hiroki   Yazaki Makoto   Hanada Ryoji   Horikoshi Yasuo  

International Journal of Hematology, Vol. 74, Iss. 4, 2001-12 ,pp. : 428-436

Springer Publishing Company

Access to resources Recommend Favorite

Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: A case report

By Sahin Fahri   Sercan Zeynep   Ertan Yesim   Ocakci Serkan   Ay Ertan   Vural Filiz   Yuksel Erdinc   Tombuloglu Murat   Saydam Guray  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 489-492

Maney Publishing

Access to resources Recommend Favorite

Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation

By Raepple D.  

Annals of Hematology, Vol. 88, Iss. 4, 2009-04 ,pp. : 319-324

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of NPM1 mutations in acute myeloid leukemia: A meta-analysis

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 275-281

Spandidos Publications

Access to resources Recommend Favorite

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

By Ruan Guo-Rui  

Annals of Hematology, Vol. 88, Iss. 2, 2009-02 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite